Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Journal of Lipid Research|September 1, 1989
High carbohydrate fat-free diet modulates epitope expression of LDL-apoB-100 and interaction of LDL with human fibroblastsS Keidar, A C Goldberg, K Cook, et al.
Metabolism: Clinical and Experimental|March 1, 1990
A high carbohydrate-fat free diet alters the proportion of heparin-bound VLDL in plasma and the expression of VLDL-apoB-100 epitopesS Keidar, A C Goldberg, K Cook, et al.
Harefuah|April 1, 1992
[Increased propensity to oxidation of LDL of hypertensives]S Keidar, C Shapira, M Kaplan, et al.
Metabolism: Clinical and Experimental|November 1, 1992
Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDLS Keidar, M Kaplan, M Rosenblat, et al.
Biochemical and Biophysical Research Communications|July 30, 1997
The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient miceS Keidar, J Attias, J Smith, et al.
British Journal of Clinical Pharmacology|December 1, 1994
Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studiesS Keidar, M Aviram, I Maor, et al.
Artery|January 1, 1989
Arterial blood derived low density lipoprotein increases platelet aggregation and macrophage cholesterol content in comparison to lipoprotein derived from veinous bloodS Keidar, M Aviram, E Grenadier, et al.
Israel Journal of Medical Sciences|May 1, 1975
Telangiectatic fistula between the conal branch of the left coronary artery and the pulmonary trunkP Atlas, J H Yahini, V Deutsch, et al.
British Heart Journal|October 1, 1976
Pulmonary hydatid embolization. Report on 2 operated cases and review of published reportsA Palant, V Deutsch, Y Kishon, et al.
Journal of Cardiovascular Pharmacology|February 10, 1998
Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapyM Aviram, O Hussein, M Rosenblat, et al.
Pageof 10